Curian Capital’s Genpact G Stock Holding History

Curian Capital’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,887	Closed	-$297K	–	153
2015 Q4	$297K	Sell	11,887 -14,997	-56%	-$371K	0.02%	386
2015 Q3	$635K	Buy	+26,884	New	+$603K	0.02%	452
2013 Q4	–	Sell	-23,409	Closed	-$442K	–	558
2013 Q3	$442K	Buy	23,409 +7,823	+50%	+$156K	0.01%	521
2013 Q2	$300K	Buy	+15,586	New	+$296K	0.01%	542

Other funds holding G

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Curian Capital's G Position: Q1 2016 in Review

Curian Capital sold out of Genpact (G) in Q1 2016, closing a stake of 11,887 shares — an estimated $297K sold.

Curian Capital first reported a position in G in Q2 2013 and held it in 4 quarters. The position peaked at $635K in Q3 2015. 221 funds tracked by Wall St. Rank hold G as of Q1 2016.

Curian Capital reported no remaining Genpact position as of Q1 2016 after selling out during the quarter.
Curian Capital sold 11,887 Genpact shares in Q1 2016, an estimated $297K.
Curian Capital first reported a position in Genpact in Q2 2013 and held it in 4 quarters.
Curian Capital's Genpact position peaked at $635K in Q3 2015.
221 funds tracked by Wall St. Rank held Genpact as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.